House Health Subcommittee grills FDA leaders over med device missteps

Despite the highest agency user fees on record, and granted new authorities to reform and accelerate medical device and biologics approvals, representatives questioned delays in getting products to patients faster.

Leave a Reply

Your email address will not be published. Required fields are marked *